Investing.com-- U.S. stock index futures ticked higher on Thursday evening after Wall Street closed sharply lower, weighed ...
Meta is preparing to launch a standalone artificial intelligence (AI) application in the second quarter of this year, ...
ST. PAUL, Minn. - Solventum Corporation (NYSE: SOLV) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 2% in after-hours trading. The healthcare technology ...
ERIE, Pennsylvania - Erie Indemnity Company (NASDAQ: ERIE) reported fourth-quarter earnings that slightly exceeded analyst expectations, sending its stock up 2.6% in after-hours t ...
Investing.com -- Shares of Entegris (NASDAQ: ENTG) surged by 6% in after-hours trading on Thursday following the announcement that the company will be joining the S&P MidCap 400 index. This move comes ...
The biopharmaceutical company posted adjusted earnings per share of $0.43, surpassing the analyst consensus of $0.11 by $0.32. Revenue for the quarter came in at $59.1 million, beating expectations of ...
The company posted adjusted earnings per share of $0.04 for the fourth quarter, beating the analyst estimate of -$0.01. Revenue came in at $126.7 million, surpassing the consensus forecast of $109.6 ...
Definitive Healthcare’s Q4 net loss ballooned to $84.7 million, or 136% of revenue, compared to a $13.4 million loss in the same quarter last year. The company attributed $97.1 million of the loss to ...
Dell Technologies (NYSE: DELL) rose 5% after fourth quarter EPS topped consensus, despite conservative guidance for the first ...
JERSEY CITY, N.J. - AvePoint, Inc. (NASDAQ: AVPT) shares plunged 13.6% after the data security and governance firm reported mixed fourth-quarter results, with earnings falling short of analyst ...
MALVERN, Pa. - CubeSmart (NYSE: CUBE) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 4.3% in after-hours trading as the self-storage operator also ...
Compared to the same quarter last year, Amphastar’s revenue increased 4.7% from $178.1 million. The company’s top-selling product in Q4 was BAQSIMI, which generated sales of $41.8 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results